EDGAR Filing Documents for 0001193125-09-077942

Form 8-K - Current report:

SEC Accession No. 0001193125-09-077942

Filing Date

2009-04-13

Accepted

2009-04-13 17:26:28

Documents

Period of Report

2009-04-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	24658
2	LETTER AGREEMENT	dex11.htm	EX-1.1	82582
3	ARTICLES OF AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION	dex31.htm	EX-3.1	66552
4	SERIES 1 PREFERRED STOCK CERTIFICATE	dex41.htm	EX-4.1	7294
5	CLASS A WARRANT, DATED APRIL 13, 2009	dex42.htm	EX-4.2	66890
6	CLASS B WARRANT, DATED APRIL 13, 2009	dex43.htm	EX-4.3	66939
7	OPINION OF STRADLING YOCCA CARLSON & RAUTH	dex51.htm	EX-5.1	13239
8	SECURITIES PURCHASE AGREEMENT	dex101.htm	EX-10.1	137787
9	GRAPHIC	g84709g20d81.jpg	GRAPHIC	32261
	Complete submission text file	0001193125-09-077942.txt		512229

Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119

Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100

CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)